Cell and Gene Therapy: Bridging Insight and Urgency
The Great Balancing Act: Navigating the Industrialization of Cell and Gene Therapy The cell and gene therapy (CGT) sector is currently undergoing a fundamental metamorphosis. We are moving away from the “discovery at all costs” era and into a high-stakes phase where biological complexity must coexist with industrial-scale predictability. For researchers and biotech leaders, the … Read more